Showing results (31-40 of 154) with videos related to
Sort By:
Pageof 16
Cardiovascular Research|July 19, 2008
Single histidine-substituted cardiac troponin I confers protection from age-related systolic and diastolic dysfunctionNathan J Palpant, Sharlene M Day, Todd J Herron, et al.Cureus|February 15, 2024
A Case of Reverse McConnell's Sign Associated With Acute Respiratory Distress Syndrome and Septic ShockBrett Curtis, Albert Ha, Jeffrey Xie, et al.Scientific Data|April 6, 2026
Long non-coding RNA profiling of hypertrophic cardiomyopathy in miceGraham A Branscom, Michael P Morley, Jonathan J Herrera, et al.European Heart Journal|March 26, 2021
Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathyNicholas A Marston, Larry Han, Iacopo Olivotto, et al.Circulation. Heart Failure|March 22, 2013
Impaired assembly and post-translational regulation of 26S proteasome in human end-stage heart failureSharlene M Day, Andras Divald, Ping Wang, et al.Nature|July 19, 2005
Dystrophic heart failure blocked by membrane sealant poloxamerSoichiro Yasuda, DeWayne Townsend, Daniel E Michele, et al.Heart Failure Clinics|March 12, 2018
Epidemiology and Clinical Aspects of Genetic CardiomyopathiesDaniele Masarone, Juan Pablo Kaski, Giuseppe Pacileo, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 30, 2021
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretationAndrea D Thompson, Adam S Helms, Anamika Kannan, et al.Journal of Genetic Counseling|October 12, 2014
Family communication in a population at risk for hypertrophic cardiomyopathyBrittany Batte, Jane P Sheldon, Patricia Arscott, et al.Circulation|May 7, 2003
Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosisSharlene M Day, Damon Duquaine, Lakshmi V Mundada, et al.Pageof 16